4.8 Article

Hsp90 activator Aha1 drives production of pathological tau aggregates

Related references

Note: Only part of the references are listed.
Review Chemistry, Medicinal

Stressing Out Hsp90 in Neurotoxic Proteinopathies

Carmen Inda et al.

CURRENT TOPICS IN MEDICINAL CHEMISTRY (2016)

Article Chemistry, Medicinal

Novobiocin Analogues That Inhibit the MAPK Pathway

Jessica A. Hall et al.

JOURNAL OF MEDICINAL CHEMISTRY (2016)

Article Chemistry, Medicinal

Diverging Novobiocin Anti-Cancer Activity from Neuroprotective Activity through Modification of the Amide Tail

Suman Ghosh et al.

ACS MEDICINAL CHEMISTRY LETTERS (2016)

Article Multidisciplinary Sciences

The Mechanism of Hsp90 ATPase Stimulation by Aha1

Annemarie Wolmarans et al.

SCIENTIFIC REPORTS (2016)

Review Pharmacology & Pharmacy

Targeting Hsp90/Hsp70-Based Protein Quality Control for Treatment of Adult Onset Neurodegenerative Diseases

William B. Pratt et al.

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 55 (2015)

Review Oncology

Maximizing the Therapeutic Potential of HSP90 Inhibitors

Lisa M. Butler et al.

MOLECULAR CANCER RESEARCH (2015)

Article Biochemistry & Molecular Biology

Hsp90 C-Terminal Inhibitors Exhibit Antimigratory Activity by Disrupting the Hsp90α/Ahal Complex in PC3-MM2 Cells

Suman Ghosh et al.

ACS CHEMICAL BIOLOGY (2015)

Article Biochemistry & Molecular Biology

Selective inhibitors of the FK506-binding protein 51 by induced fit

Steffen Gaali et al.

NATURE CHEMICAL BIOLOGY (2015)

Article Biochemistry & Molecular Biology

Hsp90-Tau Complex Reveals Molecular Basis for Specificity in Chaperone Action

G. Elif Karagoz et al.

Review Pharmacology & Pharmacy

Targeting Hsp90 and its co-chaperones to treat Alzheimer's disease

Laura J. Blair et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2014)

Article Biochemistry & Molecular Biology

Gedunin Inactivates the Co-chaperone p23 Protein Causing Cancer Cell Death by Apoptosis

Chaitanya A. Patwardhan et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2013)

Article Medicine, Research & Experimental

Accelerated neurodegeneration through chaperone-mediated oligomerization of tau

Laura J. Blair et al.

JOURNAL OF CLINICAL INVESTIGATION (2013)

Article Biochemistry & Molecular Biology

Integration of the accelerator Aha1 in the Hsp90 co-chaperone cycle

Jing Li et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2013)

Article Oncology

Hsp90 Molecular Chaperone Inhibitors: Are We There Yet?

Len Neckers et al.

CLINICAL CANCER RESEARCH (2012)

Article Medicine, Research & Experimental

A Compound That Inhibits the HOP-Hsp90 Complex Formation and Has Unique Killing Effects in Breast Cancer Cell Lines

Genaro Pimienta et al.

MOLECULAR PHARMACEUTICS (2011)

Article Pharmacology & Pharmacy

Withaferin A targets heat shock protein 90 in pancreatic cancer cells

Yanke Yu et al.

BIOCHEMICAL PHARMACOLOGY (2010)

Article Biochemistry & Molecular Biology

Celastrol Inhibits Hsp90 Chaperoning of Steroid Receptors by Inducing Fibrillization of the Co-chaperone p23

Ahmed Chadli et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2010)

Article Biochemistry & Molecular Biology

A Novel Class of Small Molecule Inhibitors of Hsp90

Fang Yi et al.

ACS CHEMICAL BIOLOGY (2008)

Article Oncology

A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cells

Tao Zhang et al.

MOLECULAR CANCER THERAPEUTICS (2008)

Review Neurosciences

Tau-mediated neurodegeneration in Alzheimer's disease and related disorders

Carlo Ballatore et al.

NATURE REVIEWS NEUROSCIENCE (2007)

Article Biochemistry & Molecular Biology

Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis

Xiaodong Wang et al.

Article Biochemistry & Molecular Biology

Celastrols as inducers of the heat shock response and cytoprotection

SD Westerheide et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2004)

Review Neurosciences

Neurodegenerative tauopathies

VMY Lee et al.

ANNUAL REVIEW OF NEUROSCIENCE (2001)